{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:21:01Z","timestamp":1760487661876,"version":"build-2065373602"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMDH"],"DOI":"10.2147\/jmdh.s528370","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:35:11Z","timestamp":1760416511000},"page":"6681-6698","source":"Crossref","is-referenced-by-count":0,"title":["The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"C\u00e9cile","family":"Gaujoux-Viala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-9287","authenticated-orcid":true,"given":"Sonia","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Bocquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeric","family":"Langu\u00e9rand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7430-2260","authenticated-orcid":true,"given":"Laura","family":"Corduri\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2059-1631","authenticated-orcid":true,"given":"G\u00e9raldine","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Le Berre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"ref1","unstructured":"Assurance Maladie. D\u00e9finition et caract\u00e9ristiques des m\u00e9dicaments biosimilaires. 2024. Available from: https:\/\/www.ameli.fr\/paris\/etablissement\/exercice-professionnel\/prescriptions\/medicaments-biosimilaires\/definition-et-caracteristiques. Accessed October 3, 2025."},{"key":"ref2","unstructured":"Troein P, Newton M, Stoddart K, Arias A. The Impact of Biosimilar Competition in Europe. Available from: https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/the-impact-of-biosimilar-competition-in-europe-2022.pdf. Accessed October 3, 2025."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e003531","DOI":"10.1136\/rmdopen-2023-003531","volume":"10","author":"Jourdain","year":"2024","journal-title":"RMD Open"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"19569","DOI":"10.1038\/s41598-022-24050-7","volume":"12","author":"Jourdain","year":"2022","journal-title":"Sci Rep"},{"key":"ref5","unstructured":"Am\u00e9liorer La Qualit\u00e9 Du Syst\u00e9me De Sant\u00e9 Et Ma\u00eetriser Les D\u00e9penses, Propositions de l\u2019Assurance Maladie pour 2025. 2024. Available from: https:\/\/www.assurance-maladie.ameli.fr\/sites\/default\/files\/2024-07_rapport-propositions-pour-2025_assurance-maladie.pdf. Accessed October 3, 2025."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rhum.2018.09.004","volume":"86","author":"Sigaux","year":"2019","journal-title":"Rev Rhum"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jbspin.2019.01.001","volume":"86","author":"Frantzen","year":"2019","journal-title":"Joint Bone Spine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.revmed.2018.10.383","volume":"40","author":"Scherlinger","year":"2019","journal-title":"Rev M\u00e9decine Interne"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40259-016-0202-5","volume":"30","author":"Beck","year":"2016","journal-title":"BioDrugs"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/19420862.2016.1267087","volume":"9","author":"Beck","year":"2017","journal-title":"mAbs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10067-020-05229-7","volume":"39","author":"Cohen","year":"2020","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"A266","DOI":"10.1016\/j.fander.2022.09.455","volume":"2","author":"Jourdain","year":"2022","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie-FMC"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/acr.24012","volume":"72","author":"Gasteiger","year":"2020","journal-title":"Arthritis Care Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000533263","volume":"92","author":"Scott","year":"2023","journal-title":"Psychother Psychosom"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.pharma.2022.08.011","volume":"81","author":"Belo-Kibabu","year":"2023","journal-title":"Ann Pharm Fr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"105322","DOI":"10.1016\/j.jbspin.2021.105322","volume":"89","author":"Levivien","year":"2022","journal-title":"Joint Bone Spine"},{"key":"ref19","unstructured":"Maladie A. Dispositif d\u2019int\u00e9ressement \u00e0 la prescription de m\u00e9dicaments biosimilaires: ce qu\u2019il faut savoir. 2024. Available From: https:\/\/www.ameli.fr\/paris\/medecin\/exercice-liberal\/facturation-remuneration\/dispositif-interessement-prescription-biosimilaires. Accessed October 3, 2025."},{"key":"ref20","unstructured":"de la Sant\u00e9 Et de la Pr\u00e9vention M. Rapport au parlement 2022 sur les exp\u00e9rimentations innovantes en sant\u00e9, Article 51 de la loi de financement de la s\u00e9curit\u00e9 sociale pour 2018. Available from: https:\/\/sante.gouv.fr\/IMG\/pdf\/rapport_parlement_article_51_2022.pdf#:~:text=du%20syst%C3%A8me%20de%20sant%C3%A9%20post-Covid,%20les%20exp%C3%A9rimentations%20article. Accessed October 3, 2025."},{"key":"ref21","unstructured":"ANSM. Modification des conditions de prescription et de d\u00e9livrance de certaines bioth\u00e9rapies utilis\u00e9es dans le traitement de maladies inflammatoires chroniques. 2024. Available from: https:\/\/ansm.sante.fr\/actualites\/modification-des-conditions-de-prescription-et-de-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques. Accessed October 3, 2025."},{"key":"ref22","unstructured":"DREES. D\u00e9mographie des professionnels de sant\u00e9 en 2023 par sp\u00e9cialit\u00e9 et mode d\u2019exercice; 2023."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00296-020-04576-7","volume":"41","author":"Gasteiger","year":"2021","journal-title":"Rheumatol Int"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"c5146","DOI":"10.1136\/bmj.c5146","volume":"341","author":"Elwyn","year":"2010","journal-title":"BMJ"},{"key":"ref25","unstructured":"Maladie A. Tout savoir sur les bioth\u00e9rapies. 2024. Available from: https:\/\/www.ameli.fr\/paris\/assure\/sante\/medicaments\/comprendre-les-differents-medicaments\/tout-savoir-sur-les-biotherapies#:~:text=Les%20bioth%C3%A9rapies%20sont%20des%20traitements%20utilisant%20des#:~:text=Les%20bioth%C3%A9rapies%20sont%20des%20traitements%20utilisant%20des. Accessed October 3, 2025."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jad.2019.10.008","volume":"262","author":"Maurin","year":"2020","journal-title":"J Affect Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e19998","DOI":"10.2196\/19998","volume":"23","author":"Magnol","year":"2021","journal-title":"J Med Internet Res"}],"container-title":["Journal of Multidisciplinary Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/107848","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/107848","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:35:16Z","timestamp":1760416516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-switch-from-reference-biologic-medicines-to-biosimilars-in-france--peer-reviewed-fulltext-article-JMDH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2147\/jmdh.s528370","relation":{},"ISSN":["1178-2390"],"issn-type":[{"value":"1178-2390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}